FT FTP Innovative Health Care 7 CA (FCOVGX)
8.642
+0.08
(+0.98%)
USD |
Mar 29 2023
Key Stats
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.22% | -- | 0.00% | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -- | -- | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Trust seeks above-average capital appreciation. Under normal circumstances, the Trust will invest at least 80% of its assets in health care companies. Health care companies are companies classified under the health care sector of the Global Industry Classification Standard (GICS(R)) which include health care equipment & supplies companies, health care providers and services companies, health care technology companies, biotechnology companies, pharmaceuticals and life sciences tools & services companies. The Trust is concentrated (i.e., invests more than 25% of Trust assets) in stocks of companies within the health care sector. |
| General | |
| Security Type | Unit Investment Trust |
| Oldest Share Symbol | FCOVGX |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | -- |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | First Trust Portfolios L.P. |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
--
-2.719B
Category Low
6.230B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
Date Unavailable
Risk
Performance Versus Category
As of March 29, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of March 29, 2023.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Seagen Inc Ordinary Shares | 4.01% | 202.23 | -0.39% |
| Gilead Sciences Inc | 3.70% | 81.29 | 0.40% |
| Merck & Co Inc | 3.47% | 104.92 | -0.58% |
| Alnylam Pharmaceuticals Inc | 3.40% | 195.91 | 3.90% |
| Regeneron Pharmaceuticals Inc | 3.37% | 819.35 | -0.92% |
| Biomarin Pharmaceutical Inc | 3.35% | 94.20 | 3.02% |
| Vertex Pharmaceuticals Inc | 3.12% | 314.24 | 0.32% |
| Repligen Corp | 3.08% | 169.30 | 1.03% |
| Stryker Corp | 3.00% | 279.03 | 0.58% |
| Agilent Technologies Inc | 2.99% | 133.85 | 0.92% |
Basic Info
| Investment Strategy | |
| The Trust seeks above-average capital appreciation. Under normal circumstances, the Trust will invest at least 80% of its assets in health care companies. Health care companies are companies classified under the health care sector of the Global Industry Classification Standard (GICS(R)) which include health care equipment & supplies companies, health care providers and services companies, health care technology companies, biotechnology companies, pharmaceuticals and life sciences tools & services companies. The Trust is concentrated (i.e., invests more than 25% of Trust assets) in stocks of companies within the health care sector. |
| General | |
| Security Type | Unit Investment Trust |
| Oldest Share Symbol | FCOVGX |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | -- |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | First Trust Portfolios L.P. |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (3-29-23) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 27.22 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 28, 2023
Fund Details
| Key Dates | |
| Inception Date | 4/20/2022 |
| Termination Date | 7/20/2023 |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Share Classes | |
| F00001DRL1 | -- |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |